Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Oral baricitinib is effective and safe for treating alopecia areata.

JAK inhibitors show promise in treating difficult skin diseases.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Dupilumab can cause psoriasis in some patients.

A new compound shows promise as a topical treatment for hair loss.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.